Alexander G Vandell

Pharmaceutical Industry 
Drug development
"Alexander Vandell"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Scarisbrick IA, Radulovic M, Burda JE, et al. (2012) Kallikrein 6 is a novel molecular trigger of reactive astrogliosis. Biological Chemistry. 393: 355-67
Scarisbrick IA, Epstein B, Cloud BA, et al. (2011) Functional role of kallikrein 6 in regulating immune cell survival. Plos One. 6: e18376
Vandell AG, Larson N, Laxmikanthan G, et al. (2008) Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines. Journal of Neurochemistry. 107: 855-70
Scarisbrick IA, Linbo R, Vandell AG, et al. (2008) Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration. Biological Chemistry. 389: 739-45
Scarisbrick IA, Sabharwal P, Cruz H, et al. (2006) Dynamic role of kallikrein 6 in traumatic spinal cord injury. The European Journal of Neuroscience. 24: 1457-69
See more...